These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34576308)

  • 1. Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction.
    Siano G; Falcicchia C; Origlia N; Cattaneo A; Di Primio C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic Localisation of Tau.
    Hanger DP; Goniotaki D; Noble W
    Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Tau in the Post-synapse.
    Regan P; Cho K
    Adv Exp Med Biol; 2019; 1184():113-121. PubMed ID: 32096033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of tau protein in health and disease.
    Guo T; Noble W; Hanger DP
    Acta Neuropathol; 2017 May; 133(5):665-704. PubMed ID: 28386764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau protein modifications and interactions: their role in function and dysfunction.
    Mietelska-Porowska A; Wasik U; Goras M; Filipek A; Niewiadomska G
    Int J Mol Sci; 2014 Mar; 15(3):4671-713. PubMed ID: 24646911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease.
    Tracy TE; Gan L
    Curr Opin Neurobiol; 2018 Aug; 51():134-138. PubMed ID: 29753269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
    Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
    Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and Pathophysiological Implications of Synaptic Tau.
    Regan P; Whitcomb DJ; Cho K
    Neuroscientist; 2017 Apr; 23(2):137-151. PubMed ID: 26908138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.
    Tracy TE; Gan L
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.
    Zhong H; Liu H; Liu H
    Curr Med Chem; 2024; 31(20):2855-2871. PubMed ID: 37031392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
    Chen F; David D; Ferrari A; Götz J
    Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospho-Tau Impairs Nuclear-Cytoplasmic Transport.
    Tripathi T; Prakash J; Shav-Tal Y
    ACS Chem Neurosci; 2019 Jan; 10(1):36-38. PubMed ID: 30480430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.
    Zhang X; Wang J; Zhang Z; Ye K
    Transl Neurodegener; 2024 Aug; 13(1):40. PubMed ID: 39107835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.